Research & Development
Research & Development

Research & Development Pipeline

Improving patients' lives through better healthcare begins with a commitment to innovation. Our research and development pipeline is where we put that commitment to work. Takeda Global Research & Development Center, Inc. dedicates its resources to the Takeda product pipeline in an effort to improve people’s lives. As a research-based pharmaceutical company efforts are currently focused on preclinical work and clinical development activities.

Compound Therapeutic Area Stage
alogliptin Diabetes mellitus NDA submitted
dexlansoprazole Gastroenterology NDA submitted
febuxostat Rheumatology NDA submitted
TAK-491 Hypertension Phase 3
hematide Chronic kidney disease (CKD) Phase 3
L21004 MDD Depression/anxiety Phase 3
SYR-322-4833 Diabetes Type 2 Phase 3
TAK-242 Sepsis Phase 3
MLNM002 Crohn’s and Ulcerative Colitis Phase 3

Our Products

Learn more about our products currently on the market.

Page Top